ZA854697B - Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor - Google Patents

Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor

Info

Publication number
ZA854697B
ZA854697B ZA854697A ZA854697A ZA854697B ZA 854697 B ZA854697 B ZA 854697B ZA 854697 A ZA854697 A ZA 854697A ZA 854697 A ZA854697 A ZA 854697A ZA 854697 B ZA854697 B ZA 854697B
Authority
ZA
South Africa
Prior art keywords
genes encoding
immunologically active
active peptides
immunization against
peptides capable
Prior art date
Application number
ZA854697A
Other languages
English (en)
Inventor
Thomas Frank Mccutchan
John Barton Dame
Jackie L Williams
Imogene Schneider
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Publication of ZA854697B publication Critical patent/ZA854697B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/29—Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA854697A 1984-06-26 1985-06-21 Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor ZA854697B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/624,564 US4707357A (en) 1984-06-26 1984-06-26 Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor

Publications (1)

Publication Number Publication Date
ZA854697B true ZA854697B (en) 1986-02-26

Family

ID=24502471

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA854697A ZA854697B (en) 1984-06-26 1985-06-21 Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor

Country Status (9)

Country Link
US (1) US4707357A (xx)
EP (1) EP0166410B1 (xx)
JP (4) JP2561238B2 (xx)
AU (1) AU596561B2 (xx)
CA (1) CA1340431C (xx)
DE (1) DE3586853T2 (xx)
DK (2) DK166284C (xx)
HK (1) HK1001823A1 (xx)
ZA (1) ZA854697B (xx)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566780B1 (fr) * 1984-07-02 1987-02-06 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un epitope caracteristique d'une proteine produite par des cellules infectees par les parasites du paludisme et compositions les contenant
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
DE3686178T2 (de) * 1985-02-07 1993-03-11 Smithkline Beckman Corp Malaria-impfstoff.
ES8800273A1 (es) * 1985-03-28 1987-11-01 Univ New York Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
EP0217877A4 (en) * 1985-04-11 1988-03-30 Inst Medical W & E Hall VERY REPEATABLE ANTIGENS FROM PLASMODIUM FALCIPARUM.
US4957869A (en) * 1985-07-12 1990-09-18 New York University Immunogenic peptide corresponding to P. vivax CS protein
EP0229829B1 (en) * 1985-07-12 1995-02-22 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
IT1187710B (it) * 1985-07-25 1987-12-23 Eniricerche Spa Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche
EP0254862A1 (en) * 1986-06-26 1988-02-03 BEHRINGWERKE Aktiengesellschaft Vaccines against protozoan parasites
US5019384A (en) * 1986-06-30 1991-05-28 Massachusetts Institute Of Technology Immunonodulating compositions and their use
US5225530A (en) * 1986-07-16 1993-07-06 Eniricerche S.P.A. Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections
IT1196501B (it) * 1986-07-16 1988-11-16 Eniricerche Spa Polipeptide utile per la preparazione di vaccini per la malaria e di kits diagnostici per la determinazione di affezioni malariche
IT1198225B (it) * 1986-12-04 1988-12-21 Eniricerche Spa Polipeptidi immunologicamente attivi utili per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antisporozoita
IT1198233B (it) * 1986-12-23 1988-12-21 Eniricerche Spa Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano
US4957738A (en) * 1987-01-14 1990-09-18 Patarroyo Manuel E Protein copolymer malaria vaccine
CA1329124C (en) * 1987-02-02 1994-05-03 Jerald C. Sadoff Conjugate malaria vaccine
FR2610631B1 (fr) * 1987-02-09 1989-11-24 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum dans les hepatocytes, et leurs utilisations, notamment pour le diagnostic du paludisme ou dans des compositions de vaccins contre le paludisme
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
ATE118822T1 (de) * 1987-06-26 1995-03-15 Syntro Corp Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
US5273876A (en) * 1987-06-26 1993-12-28 Syntro Corporation Recombinant human cytomegalovirus containing foreign gene
IT1223301B (it) * 1987-09-11 1990-09-19 Eniricerche Spa Polipeptidi sequenziali immunologicamente attivi
AT388934B (de) * 1987-11-13 1989-09-25 Wellcome Found Rekombinationskonjugatprotein und neue vakzinen
IT1233419B (it) * 1987-12-11 1992-03-31 Eniricerche Spa Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
EP0418310B1 (en) * 1988-05-02 1996-06-19 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Gene for encoding a human malaria vaccine antigen
US5028425A (en) * 1988-07-07 1991-07-02 The United States Of America As Represented By The Department Of Health And Human Services Synthetic vaccine against P. falciparum malaria
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
KR910700352A (ko) * 1988-12-21 1991-03-14 스미스클라인 바이올로지칼즈(s.a.) 곤충 세포내에서 플라스모듐 서컴스포로 조이트 단백질의 발현
ES2055785T3 (es) * 1989-01-17 1994-09-01 Eniricerche Spa Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.
NZ233255A (en) * 1989-04-11 1993-02-25 Chiron Corp Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
AU5649290A (en) * 1989-04-12 1990-11-05 New York University Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine
CA2015722A1 (en) * 1989-05-03 1990-11-03 Mitchell S. Gross Malaria vaccine
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
AU7163091A (en) * 1989-12-12 1991-07-18 Biomedical Research Institute Novel malarial sporozoite peptide antigens
US5695957A (en) * 1990-02-05 1997-12-09 Imperial Exploitation Limited Polypeptides and DNA encoding same, associated with human malaria parasites
CA2076035A1 (en) * 1990-02-22 1991-08-23 Andrew P. Waters Antigenic proteins of plasmodium
GB9015888D0 (en) * 1990-07-19 1990-09-05 Smithkline Biolog Vectors
US5095093A (en) * 1990-11-06 1992-03-10 The United States Of America As Represented By The Secretary Of The Navy Protective four amino acid epitope against Plasmodium vivax malaria
US6566121B1 (en) 1991-06-13 2003-05-20 Albert Einstein College Of Medicine Of Yeshiva University Insertional mutations in mycobacteria
US5786214A (en) * 1994-12-15 1998-07-28 Spinal Cord Society pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
NO986133D0 (no) * 1998-12-23 1998-12-23 Preben Lexow FremgangsmÕte for DNA-sekvensering

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033776A1 (de) * 1980-09-09 1982-04-22 Behringwerke Ag, 3550 Marburg Verfahren zur vermehrung von protozoen
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
EP0175261B1 (en) * 1984-09-12 1991-12-11 Chiron Corporation Hybrid particle immunogens
DE3686178T2 (de) * 1985-02-07 1993-03-11 Smithkline Beckman Corp Malaria-impfstoff.

Also Published As

Publication number Publication date
JP2561238B2 (ja) 1996-12-04
AU4399085A (en) 1986-01-02
JP2537027B2 (ja) 1996-09-25
EP0166410A2 (en) 1986-01-02
EP0166410B1 (en) 1992-11-25
HK1001823A1 (en) 1998-07-10
DK166284B (da) 1993-03-29
JPH06225768A (ja) 1994-08-16
DK166155B (da) 1993-03-15
DE3586853T2 (de) 1993-10-07
JPS61149093A (ja) 1986-07-07
CA1340431C (en) 1999-03-16
US4707357A (en) 1987-11-17
JPH07110876B2 (ja) 1995-11-29
DK166284C (da) 1993-08-23
DK191991D0 (da) 1991-11-26
JPH07265087A (ja) 1995-10-17
JPH07265086A (ja) 1995-10-17
DK289185A (da) 1985-12-27
JP2537028B2 (ja) 1996-09-25
DK191991A (da) 1991-11-26
DK289185D0 (da) 1985-06-26
EP0166410A3 (en) 1987-11-25
AU596561B2 (en) 1990-05-10
DE3586853D1 (de) 1993-01-07
DK166155C (da) 1993-08-09

Similar Documents

Publication Publication Date Title
HK1001823A1 (en) Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
GB2178041B (en) Antigenic modification of peptides
NZ228380A (en) Azahomocyclostatine-containing peptides and nitrile-containing precursor
EP0193413A3 (en) Cloning restriction and modification genes
PL256012A1 (en) Method of obtaining peptides
EP0217634A3 (en) Sequencing of peptides
IL75927A0 (en) Retroviral vaccines and vectors and methods for their construction
GB8516442D0 (en) Cloned antigen
AU6698786A (en) Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
IL71031A (en) Preparation of somatocrinin and intermediate peptides employed therein
NZ215023A (en) Vaccine against plasmodium falciparum and antigenic peptides
ZA86338B (en) Novel growth hormone-releasing peptides and method of treating mammals therewith
EP0223711A3 (en) Protective synthetic peptide against malaria and encoding gene
GR862451B (en) Peptide antagonists of neurokinin b and opthalmic solutions containing them
EP0222412A3 (en) Method of producing peptides
NZ236357A (en) Vaccine and polypeptide containing immunogenic determinant from flanking region of plasmodium surface protein
EP0175613A3 (en) Immunogenic hav peptides
AU4885885A (en) Antigenic peptides of ldh-c4 antisera
EP0404835A4 (en) Novel recombinant vaccinia virus expression vectors and method of selecting same
IL78314A0 (en) Expression vectors and methods for the production of recombinant human renin
GB2219590B (en) Antigenic polypeptides of taena ovis
GB2193206B (en) Preparation of taurine-containing peptides
ZA859297B (en) Process and vaccine
IE852241L (en) Peptides and vaccines against malaria
AU562962B2 (en) Molecular cloning and characterisation of the gene sequence coding for human relaxin